跳至主要内容
临床试验/NCT04081779
NCT04081779进行中(未招募)不适用

IMPACT: Improving Access to Cancer Survivorship Via Telehealth

Fred Hutchinson Cancer Center1 个研究点 分布在 1 个国家目标入组 261 人开始时间: 2020年2月19日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
261
试验地点
1
主要终点
Initial participation rate of cancer survivors identified from community-based or partner practices, and Cancer Surveillance System of Western Washington

研究概览

简要总结

This trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural areas. Patients living in rural areas often face barriers to survivorship care and report unmet needs. A survivorship care plan created by the patient (self-generated) may help them to better transition from oncology to primary care and improve communication between care teams in order to meet these needs and create better health outcomes. Telehealth is a way of delivering health care services from a distance, including patient education. Combining a self-generated survivorship care plan with telehealth education may help to improve knowledge and self-efficacy in cancer survivors.

详细描述

OUTLINE:

Patients complete a questionnaire at baseline (paper, online, or telephone-based) and have medical records reviewed and are assigned to 1 of 3 cohorts.

COHORTS A AND B: Patients are randomized to 1 of 2 arms.

ARM I: Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).

ARM II: Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Care Provider, Investigator)

盲法说明

Personnel other than the statisticians and lay health educators

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cancer survivors who have completed curative therapy within the past 5 years (may still currently be on long-term/targeted non-cytotoxic agent maintenance therapy, e.g., tamoxifen or aromatase inhibitors for breast cancer survivors; androgen deprivation therapy for prostate cancer survivors)
  • History of either adult-onset (age >= 18) lymphoma, breast, colorectal, lung, or prostate cancer
  • Able to perform all study requirements, including responding to questionnaires
  • Willing to be randomized
  • Capable of providing informed consent
  • Consent to release oncology and primary care medical records
  • English or Spanish speakers
  • PRIMARY CARE PROVIDERS: PCPs responsible for delivering primary care to IMPACT study participants will be contacted about participating in the study after participant enrollment into the study.
  • ONCOLOGY STAFF: Oncology Staff (Oncologists, Nurse Practitioners, Physician's assistants) will be recruited from sites involved in the IMPACT study
  • CLINIC ADMINISTRATORS: Clinic administrators will be recruited from sites involved in the IMPACT study

排除标准

  • Currently on palliative or hospice care, or considering transferring to such care within the next 3 months
  • Lacks telephone access
  • Lacks mailing address or ability to receive study materials electronically
  • Currently being followed in a pediatric clinical setting (either for primary care or for cancer care)
  • History of having had > 1 cancer type diagnosed and treated (exception is for skin cancers treated with surgical excision alone; also, individuals who only have had relapse of their initial cancer remain eligible so long as they have completed curative therapy and meet all other eligibility criteria)

研究组 & 干预措施

Arm I (patient-generated SCP)

Active Comparator

Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).

干预措施: Survivorship Care Plan (Other)

Arm I (patient-generated SCP)

Active Comparator

Patients receive a self-generated SCP (i.e., generated from baseline questionnaire responses).

干预措施: Questionnaire Administration (Other)

Arm II (patient-generated SCP, counseling)

Experimental

Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.

干预措施: Survivorship Care Plan (Other)

Arm II (patient-generated SCP, counseling)

Experimental

Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.

干预措施: Educational Intervention (Other)

Arm II (patient-generated SCP, counseling)

Experimental

Patients receive a self-generated SCP as in Arm I. Patients also receive a 30-minute telephone-based educational counseling session on survivorship care administered by trained lay health counselors.

干预措施: Questionnaire Administration (Other)

Arm III (generic information)

Active Comparator

Patients receive generic information on survivorship care on study.

干预措施: Questionnaire Administration (Other)

Arm III (generic information)

Active Comparator

Patients receive generic information on survivorship care on study.

干预措施: Supportive Care (Other)

Arm IV (generic information, patient-generated SCP)

Active Comparator

Patients receive generic information on survivorship care and a self-generated SCP as in Arm I on study.

干预措施: Questionnaire Administration (Other)

Arm IV (generic information, patient-generated SCP)

Active Comparator

Patients receive generic information on survivorship care and a self-generated SCP as in Arm I on study.

干预措施: Supportive Care (Other)

Arm IV (generic information, patient-generated SCP)

Active Comparator

Patients receive generic information on survivorship care and a self-generated SCP as in Arm I on study.

干预措施: Survivorship Care Plan (Other)

Arm V (generic information, patient-generated SCP, counseling)

Experimental

Patients receive generic information on survivorship care as well as a self-generated SCP as in Arm I and a telephone-based educational counseling session as in Arm II on study.

干预措施: Survivorship Care Plan (Other)

Arm V (generic information, patient-generated SCP, counseling)

Experimental

Patients receive generic information on survivorship care as well as a self-generated SCP as in Arm I and a telephone-based educational counseling session as in Arm II on study.

干预措施: Educational Intervention (Other)

Arm V (generic information, patient-generated SCP, counseling)

Experimental

Patients receive generic information on survivorship care as well as a self-generated SCP as in Arm I and a telephone-based educational counseling session as in Arm II on study.

干预措施: Questionnaire Administration (Other)

Arm V (generic information, patient-generated SCP, counseling)

Experimental

Patients receive generic information on survivorship care as well as a self-generated SCP as in Arm I and a telephone-based educational counseling session as in Arm II on study.

干预措施: Supportive Care (Other)

结局指标

主要结局

Initial participation rate of cancer survivors identified from community-based or partner practices, and Cancer Surveillance System of Western Washington

时间窗: Up to 8 weeks

Accuracy of survivors' self-generated survivorship care plans (SCPs) in relation to those based on medical record abstraction

时间窗: Up to 8 weeks

Will measure the accuracy of participants' SCPs by comparing their self-reported medical history collected via questionnaire, with data abstracted from medical records. Accuracy will be reported by percentage of missing data in the self-generated SCP compared to medical records, and percentage of incorrect data in the self-generated SCP compared to medical records.

Proportion of survivors who receive the phone-based education session within the study time period

时间窗: Up to 8 weeks

Proportion of survivors who complete the follow-up questionnaire within the study time period

时间窗: Up to 8 weeks

Response rate among primary care providers (PCPs) to the PCP survey

时间窗: Up to 8 weeks

次要结局

  • PCP self-efficacy towards survivorship care(Up to 8 weeks)
  • Participant perceived self-efficacy: questionnaire using the PROMIS Global 10 and health related self-efficacy scales(Up to 8 weeks)
  • Survivorship knowledge(Up to 8 weeks)
  • Local oncology clinics' attitudes towards survivorship care implementation(Up to 8 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

已完成
不适用
Ostomy Telehealth For Cancer SurvivorsColostomy Stoma
NCT02974634University of Pennsylvania216
进行中(未招募)
3 期
Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal CancerLung Non-Small Cell CarcinomaStage I Colorectal Cancer AJCC v8Stage I Lung Cancer AJCC v8Stage IA1 Lung Cancer AJCC v8Stage IA2 Lung Cancer AJCC v8Stage IA3 Lung Cancer AJCC v8Stage IB Lung Cancer AJCC v8Stage II Colorectal Cancer AJCC v8Stage II Lung Cancer AJCC v8Stage IIA Colorectal Cancer AJCC v8Stage IIA Lung Cancer AJCC v8Stage IIB Colorectal Cancer AJCC v8Stage IIB Lung Cancer AJCC v8Stage IIC Colorectal Cancer AJCC v8Stage III Colorectal Cancer AJCC v8Stage III Lung Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Stage IIIA Lung Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8Stage IIIB Lung Cancer AJCC v8Stage IIIC Colorectal Cancer AJCC v8Stage IIIC Lung Cancer AJCC v8
NCT04428905City of Hope Medical Center403
已完成
不适用
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in WisconsinCancer SurvivorHealthy SubjectStage I Colorectal CancerStage IA Breast CancerStage IB Breast CancerStage IIA Breast CancerStage IIA Colorectal CancerStage IIB Breast CancerStage IIB Colorectal CancerStage IIC Colorectal CancerStage IIIA Breast CancerStage IIIA Colorectal CancerStage IIIB Breast CancerStage IIIB Colorectal CancerStage IIIC Breast CancerStage IIIC Colorectal Cancer
NCT02677389University of Wisconsin, Madison100
已完成
不适用
Empowering Cancer Survivors Through Information TechnologyCancer Survivor
NCT01593618Masonic Cancer Center, University of Minnesota53
已完成
不适用
Survivor Stories: Impact on Cancer Patients' Quality of Life and Follow-upBreast Cancer
NCT00929084Washington University School of Medicine228